PERI-EDU University Education
Titanium is highly corrosion resistant, but it is not completely inert. Ions and particles can arise during placement, function, maintenance or treatment. Their presence can influence cells, yet detection alone does not prove that titanium caused peri-implantitis.
Passivation protects titanium
Titanium rapidly forms a thin oxide film when exposed to oxygen and water. This passive layer limits electrochemical dissolution. Damage can be repaired by repassivation when the local environment permits it.
| Concept | Material process | Clinical relevance |
|---|---|---|
| Passive oxide film | A thin titanium oxide layer separates metal from the environment. | Reduces corrosion and interacts with proteins, cells and biofilm. |
| Repassivation | The oxide film reforms after exposure of fresh metal. | Helps resist isolated mechanical injury. |
| Oxide disruption | Friction, abrasion or instrumentation removes part of the film. | Temporarily exposes reactive metal and can release debris. |
| Chemical destabilization | Low pH and reactive species alter electrochemical conditions. | Can increase ion release in experimental settings. |
Corrosion in the oral environment
The oral cavity provides electrolytes, changing pH, oxygen gradients, proteins and microbial metabolites. Implant, abutment and prosthetic materials can create crevice and galvanic conditions.
- Crevice corrosion: restricted fluid exchange creates a locally aggressive environment.
- Galvanic corrosion: connected dissimilar materials create an electrochemical current.
- Pitting: localized breakdown of the passive film produces small corrosion sites.
- Fretting corrosion: repetitive micromotion disrupts the film and accelerates attack.
- Inflammation-associated corrosion: low pH and reactive oxygen species may alter surface stability.
Inflammation can make the environment more corrosive, while material products can stimulate cells. Clinical studies often cannot determine which process began first.
Wear and tribocorrosion
Wear is mechanical material loss. Tribocorrosion combines wear and corrosion: friction removes the passive film, the environment attacks exposed metal, and repeated repassivation cycles generate ions and particles.
| Source | Mechanical event | Possible product |
|---|---|---|
| Implant insertion | Thread-bone friction abrades surface peaks. | Particles near thread crests and within the osteotomy. |
| Implant-abutment interface | Functional micromotion and fretting. | Metal debris and ions at the connection. |
| Loose components | Abnormal movement increases repeated contact. | Greater local debris and mechanical damage. |
| Professional instrumentation | Instruments contact the implant surface. | Scratches and displaced oxide. |
| Implantoplasty | Rotary smoothing removes exposed threads. | Substantial titanium debris. |
Particle size, shape, oxide state and protein coating influence cellular uptake. One experimental particle preparation cannot represent every clinical exposure.
How titanium is detected
| Method | Information provided | Limitation |
|---|---|---|
| Histology | Tissue architecture and visible material. | Does not identify titanium reliably without elemental analysis. |
| SEM with EDS | Particle morphology and elemental composition. | Small sampling area and limited detection of dissolved ions. |
| ICP-MS | Sensitive total elemental concentration. | Loses spatial information and particle form. |
| Elemental mapping | Spatial distribution of metals. | Requires specialized equipment and preparation. |
| Macrophage markers | Identifies macrophage-rich tissue responses. | Does not establish the source or causal role of particles. |
Titanium signals may originate from placement, wear, maintenance, implantoplasty or contamination. Particles are also found around clinically healthy implants.
Cellular responses to particles and ions
Macrophages can phagocytose titanium particles. Experimental studies report inflammasome activation, cytokine release, support of osteoclast activity and impairment of osteoblast function under selected exposure conditions.
- Macrophage responses depend on dose, particle preparation and microbial contamination.
- Inflammasome activation demonstrates mechanistic plausibility but not clinical disease initiation.
- Pro-inflammatory signaling may support osteoclast differentiation.
- High experimental particle loads can reduce osteoblast viability and osteogenic function.
- T-lymphocyte activation is not equivalent to a validated diagnosis of titanium allergy.
Titanium and peri-implantitis
Peri-implantitis is a plaque-associated inflammatory disease with progressive supporting-bone loss. Material degradation may interact with this process, but laboratory, tissue and clinical evidence must be interpreted separately.
| Evidence type | Finding | Boundary |
|---|---|---|
| Cell culture | Particles can provoke inflammatory signaling. | Experimental doses may not match clinical exposure. |
| Animal models | Debris can alter local inflammation or bone response. | Does not establish routine human incidence. |
| Human tissue studies | Titanium is often detected around implants. | Association may reflect disease, instrumentation or treatment. |
| Cross-sectional studies | Particle burden can be compared with peri-implant status. | Cannot establish temporal direction. |
Titanium measurements do not replace diagnosis based on bleeding or suppuration, probing-depth changes and progressive bone loss.
Hypersensitivity and suspected intolerance
True immune-mediated reactions to titanium are considered uncommon and remain difficult to define. Infection, failed osseointegration, cement, mechanical problems and reactions to other materials can produce similar symptoms.
- Patch testing is limited by poor skin penetration and the absence of a universally validated titanium reagent.
- Lymphocyte transformation and MELISA-type tests have uncertain thresholds and predictive validity.
- Histology and elemental analysis can describe tissue but do not prove systemic hypersensitivity.
- Routine pre-implant titanium allergy screening is not supported.
- Use the term “suspected material-related reaction” until a structured differential assessment supports a specific diagnosis.
Clinical prevention and investigation
- Use controlled placement torque and avoid unnecessary insertion-removal cycles.
- Verify component compatibility, connection fit, screw preload and occlusal design.
- Control biofilm while minimizing avoidable surface damage during maintenance.
- Capture debris and use copious irrigation when implantoplasty is selected.
- In unexplained failure, assess infection, position, loading, cement, medication and tissue pathology.
- Seek oral medicine, pathology, dermatology or biomaterials expertise in unresolved cases.
Clinical synthesis
- Titanium resists corrosion through a passive oxide layer.
- Mechanical damage and aggressive chemistry can release ions and particles.
- Tribocorrosion couples friction with electrochemical degradation.
- Macrophage uptake demonstrates interaction but not causation.
- Particles also occur around clinically healthy implants.
- Routine allergy testing does not reliably screen for titanium intolerance.
- Interpret biofilm, mechanics, materials and host response together.
Download the full educational material
The full PDF expands titanium passivation, corrosion mechanisms, tribocorrosion, particle sources, analytical methods, cellular responses, evidence limitations and clinical investigation.
Download the full educational material (PDF)
Selected references
- Chen L, et al. Titanium particles in peri-implantitis: distribution, pathogenesis and prospects. Int J Oral Sci. 2023.
- Kheder W, et al. Impact of tribocorrosion and titanium particle release. Jpn Dent Sci Rev. 2021;57:182-189.
- Noronha Oliveira M, et al. Dental implants-associated release of titanium particles. Clin Oral Implants Res. 2018;29:1085-1100.
- Müller-Heupt LK, et al. Diagnostic tests for titanium hypersensitivity. Int J Implant Dent. 2022;8:29.
- Müller-Heupt LK, et al. German S3 guideline on titanium hypersensitivity. Int J Implant Dent. 2022;8:51.
- Alvarez MBR, et al. Titanium Particles After Implantoplasty. 2025.
Explore related PERI-EDU resources
#UniversityEducation #OnlineCourses #ClinicalCases #PERIEDU #Titanium #Tribocorrosion #DentalImplants #PeriImplantitis
This material supports biomaterial-aware implant care and differential diagnosis. It does not establish material causation in an individual patient.
This work was co-funded by the European Union under grant agreement No. 2024-1-PL01-KA220-HED-000251208. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the Foundation for the Development of the Education System (FRSE). Neither the European Union nor FRSE can be held responsible for them.